Overview
Announcements

Ordinary Rebalance | Solactive China Healthcare Disruption Index | Effective Date 1st December 2022

Solactive China Healthcare Disruption Index:

In the ordinary rebalancing effective open December 01, 2022 the following index composition was implemented:

3SBIO INC 1.3032 %
AIM VACCINE CO LTD 1.7454 %
AK MEDICAL HOLDINGS LTD 0.5557 %
AKESO INC 1.825 %
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD 5.5959 %
ANGELALIGN TECHNOLOGY INC 1.0565 %
CANSINO BIOLOGICS INC 2.1093 %
CHINA MEDICAL SYSTEM HOLDINGS LTD 1.7984 %
CSPC PHARMACEUTICAL GROUP LTD 7.7217 %
GENSCRIPT BIOTECH CORP 2.7063 %
GRAND PHARMACEUTICAL GROUP LTD 0.9449 %
GUSHENGTANG HOLDINGS LTD 0.6305 %
HANSOH PHARMACEUTICAL GROUP CO 5.662 %
INNOCARE PHARMA LTD 1.2637 %
INNOVENT BIOLOGICS INC 3.0422 %
JD HEALTH INTERNATIONAL INC 8.2672 %
JOINN LABORATORIES CHINA C-H 2.2831 %
KEYMED BIOSCIENCES INC 0.9159 %
LIFETECH SCIENTIFIC CORP 0.7527 %
LIVZON PHARMACEUTICAL GROUP INC 2.286 %
LUYE PHARMA GROUP LTD 0.699 %
MICROPORT SCIENTIFIC CORP 2.1631 %
PING AN HEALTHCARE AND TECHNOL 1.4102 %
REMEGEN CO LTD-H 2.4011 %
SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD 3.3217 %
SHANGHAI BIO-HEART BIOLOGI-H 0.2967 %
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD 6.5379 %
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO LTD 0.8276 %
SHANGHAI JUNSHI BIOSCIENCES CO LTD 3.8286 %
SHANGHAI MICROPORT MEDBOT GR 1.8565 %
SIMCERE PHARMACEUTICAL GROUP 1.7645 %
SINO BIOPHARMACEUTICAL LTD ORD 5.5813 %
WUXI APPTEC CO LTD 7.3941 %
WUXI BIOLOGICS CAYMAN INC 7.727 %
ZAI LAB LTD 1.725 %